All Clinical Resources

1 - 12 of 148 results

An Evolving Treatment Paradigm for Chronic Heart Failure in Primary Care

Industry Webcast Sponsored by Novartis Pharmaceuticals Corporation; Not for CME/CE Credit

This program will review recent developments in the treatment of patients with chronic heart failure and discuss the important role of the primary care physician.


lipoprotein cell close up

Lipoprotein(a) Learning Module

An Adaptive Learning Experience Sponsored by Novartis Pharmaceuticals Corporation; Not for CME/CE CreditThis course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

Lipoprotein(a) is a genetically determined LDL-C like particle that is uniquely proatherogenic, prothrombotic, and proinflammatory. While emerging therapies are on the horizon, there are no current FDA approved medicinal treatment options for Lp(a). Understanding the prevalence and need to test for Lp(a) will help your patients mitigate potential cardiovascular risks via lifestyle modification and informing clinical practice. This interactive module will cover: • The differences between LDL-C and Lp(a) • Testing and incidence of Lp(a), as well as associated diseases • Cardiovascular risk and risk-enhancing factors that can lead to cardiovascular events • Lifestyle management and risk factor mitigation


Revisiting the Use of Oral Corticosteroids in Asthma: Benefits and Risks

Industry Webcast Sponsored by AstraZeneca; Not for CME/CE Credit


The Interconnected Cardio-Renal-Metabolic (CRM) Systems

Industry Podcast Series Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC; Not for CME/CE Credit


Close to the heart logo

T2D - Close to the Heart: The Importance of Recognizing CV Risk in T2DM

Industry Podcast Series Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.; Not for CME/CE Credit

Episode 1: Listen as Dr. Eden Miller and Dr. James O’Keefe discuss how diabetes can affect cardiovascular health. These key experts will also review key cardiovascular outcomes trials and their impact on treatment guidance for patients with type 2 diabetes. Episode 2: Dr. Eden Miller and Dr. James O’Keefe discuss the impact of cardiovascular risk factors on patients with type 2 diabetes, and how leading medical associations prioritize cardiovascular risk in patient care. Episode 3: Dr. Eden Miller and Dr. James O’Keefe discuss the effect of cardiovascular disease on mortality in patients with type 2 diabetes, and the need for a collaborative approach to patient care.


Close to the Heart: The Importance of Recognizing Cardiovascular (CV) Risk in Type 2 Diabetes Mellitus (T2DM)

Industry Webcast Series Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC; Not for CME/CE Credit

Episode 1: Listen as Dr. John Anderson and Dr. Pam Taub discuss how diabetes can affect cardiovascular health. These key experts will also review key cardiovascular outcomes trials and their impact on treatment guidance for patients with type 2 diabetes. Episode 2: Dr. John Anderson and Dr. Pam Taub discuss the impact of cardiovascular risk factors on patients with type 2 diabetes, and how leading medical associations prioritize cardiovascular risk in patient care. Episode 3: Dr. John Anderson and Dr. Pam Taub discuss the effect of cardiovascular disease on mortality in patients with type 2 diabetes, and the need for a collaborative approach to patient care.


COVID-19 Disease State Podcast Series

Industry Podcast Series Sponsored by GlaxoSmithKline; Not for CME/CE Credit


The Continuum of Heart Failure

Industry Podcast Series Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC. Not for CME/CE Credit

• Chapter 1 | The Continuum of Heart Failure: Classifying Heart Failure Listen to 2 key experts as they review the types, classification, and pathophysiology of heart failure. • Chapter 2 | The Continuum of Heart Failure: The Interconnected Nature of the Cardio-Renal-Metabolic (CRM) Systems The cardiovascular, renal, and metabolic systems are interconnected. Listen as Melissa Magwire, RN,MSN,CDE and James O’Keefe, MD discuss how these three systems impact each other, and the effect that these connections have on patients with heart failure. • Chapter 3 | The Continuum of Heart Failure: Heart Failure and Type 2 Diabetes: Assessment of Patient Care Listen as Melissa Magwire, RN,MSN,CDE and James O’Keefe, MD explore the link between heart failure and diabetes through a patient case. This content is developed exclusively by or on behalf of the industry sponsor through a third party and is not reviewed by Pri-Med. The content and opinions expressed are those of the sponsor or presenters and may not reflect the views of Pri-Med.


woman holding her stomach speaking with a doctor

Please join us in a clinical review of exciting Phase 4 data and the latest post-marketing information on a proactive treatment that may help your IBS-D patients. IBS-D is a chronic functional disorder of the GI system that affects approximately 16 million people and 40% suffers remain undiagnosed.


FAQ for HIV for the Clinician in Practice

Guest: Stephen Symes, MD, FACP